A new study warns that a popular class of cancer and rheumatoid arthritis drugs could increase the risk of skin cancer and other adverse health effects.…
Side effects of the rheumatoid arthritis and ulcerative colitis drug Xeljanz may result in the development of serious and potentially lethal pulmonary embolism. Lawsuits are being reviewed by lawyers nationwide.…
The FDA has approved higher dose formulations of extended release Xeljanz, despite concerns over the risk of potentially fatal blood clots.…
A new report warns of fatal dosing errors linked to methotrexate, due to confusion over when the highly toxic drug should be taken, and how often.…
A new study finds that nearly a third of those diagnosed with lupus use prescription opioid pain medications, despite recommendations against the practice.…
Xeljanz side effects may increase the risk of pulmonary embolism by a factor of five when taken at higher doses, according to the preliminary findings of a clinical trial.…
Pfizer is suing Ajanta Pharma over plans to release a generic version of Xeljanz years before its patent protection is scheduled to run out.…
A new report finds that problems with breast implants were hidden for years by lax medical device injury reporting rules and lax enforcement.…
A new study links drugs like Humira, Enbrel and Remicade to an increased risk of permanent nerve damage.…
The FDA has approved Actemra for use in some children, despite concerns over heart problems, infections and other health risks.…
